Skip to main content
Genesystem Co., Ltd logo

Genesystem Co., Ltd — Investor Relations & Filings

Ticker · 363250 ISIN · KR7363250002 KO Manufacturing
Filings indexed 173 across all filing types
Latest filing 2026-03-31 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 363250

About Genesystem Co., Ltd

https://genesystem.co.kr/

Genesystem Co., Ltd. is a biotechnology engineering company specializing in the development and commercialization of molecular diagnostic solutions for point-of-care testing (POCT) applications. The company focuses on making Polymerase Chain Reaction (PCR) testing faster, simpler, and more accessible for on-site use. It develops and markets rapid PCR platforms, proprietary reagents, and biochip-based products. Key technologies include ultra-fast PCR, miniaturized heating modules, and multiplex biochip systems that enable precise and convenient analysis. Genesystem's solutions serve various markets, including human healthcare for pathogen detection and food safety for identifying foodborne pathogens and meat authentication.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시) (제3자배정 유상증자)
Share Issue/Capital Change Classification · 93% confidence The document is a voluntary disclosure announcing the results of a paid-in capital increase via third-party allotment, detailing the number of shares issued, issuance amount, board resolution date, payment date, and listing plan. This fits the category for announcements of new share issues or capital structure changes.
2026-03-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a Korean "주식등의 대량보유상황보고서" (“Large Shareholding Report”) disclosing detailed holdings and changes by a major shareholder (and related parties), including share counts, percentages, reasons for variation, and insider exercises of options. This aligns precisely with the “Major Shareholding Notification” category (Code: MRQ).
2026-03-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The provided document is a Korean-language report titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing personal share ownership and changes for a company officer (박영원). It lists the number of shares held, changes in holdings, ratios, acquisition dates, etc. This fits the description of insider transactions or holdings by directors/executives. Therefore, it is classified as a Director’s Dealing (DIRS).
2026-03-24 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 16th fiscal year (2025) of Genesystem Co., Ltd. It contains comprehensive information including company overview, history, capital changes, shareholding status, and governance details. In the South Korean regulatory context, the 'Business Report' (사업보고서) is the equivalent of the US 10-K annual report, providing full financial and operational disclosure for the fiscal year. FY 2025
2026-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 93% confidence The document is titled “감사보고서 제출” (Audit Report Submission) and contains detailed auditor’s opinions, consolidated and separate financial statement figures, and audit-related notes. It is a standalone audit report, not a brief announcement or a full annual report. Therefore, it matches the Audit Report / Information category. FY 2025
2026-03-23 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for GeneSystem. It contains the meeting agenda, details on board member appointments, financial statement approval, and management reports. While it includes some management report content (Section III), the primary purpose of the document is to formally notify shareholders of the upcoming Annual General Meeting (AGM) and provide the necessary proxy/governance information for that meeting. This aligns with the definition of AGM-R (AGM Information/Materials).
2026-03-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.